CAS: 867160-71-2 - cis-3-(8-amino-1-(2-phenyl-7-quinolinyl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol

Fórmula: C₂₆H₂₃N₅O

InChI: InChI=1/C26H23N5O/c1-26(32)14-19(15-26)25-30-22(23-24(27)28-11-12-31(23)25)18-8-7-17-9-10-20(29-21(17)13-18)16-5-3-2-4-6-16/h2-13,19,32H,14-15H2,1H3,(H2,27,28)/t19-,26+

Chave InChI: InChIKey=PKCDDUHJAFVJJB-VLZXCDOPNA-N

SMILES: OC1(C)CC(C2=NC(C=3C=CC=4C=CC(=NC4C3)C5=CC=CC=C5)=C6C(=NC=CN26)N)C1

Sinónimos:

• Cyclobutanol, 3-[8-amino-1-(2-phenyl-7-quinolinyl)imidazo[1,5-a]pyrazin-3-yl]-1-methyl-, cis-
• Linsitinib
• Osi 906Aa
• Osi-906

OSI-906 (Linsitinib)

CAS: 867160-71-2

• Fórmula: C₂₆H₂₃N₅O
• Pureza: 98%
• Cor e Forma: Solid
• Peso molecular: 421.4937

Linsitinib

CAS: 867160-71-2

OSI-906 (Linsitinib (OSI-906)) is an orally bioavailable small molecule inhibitor of the insulin-like growth factor …

• Fórmula: C₂₆H₂₃N₅O
• Pureza: 99.8%
• Cor e Forma: Solid
• Peso molecular: 421.49

Linsitinib

CAS: 867160-71-2

Dual IGF-1R and InsR kinase inhibitor; antineoplastic

• Fórmula: C₂₆H₂₃N₅O
• Pureza: Min. 95%
• Cor e Forma: Off-White To Yellow Solid
• Peso molecular: 421.49 g/mol

Linsitinib

CAS: 867160-71-2

Applications Linsitinib is a small-molecule dual insulin-like growth factor-1 receptor (IGF-IR) and insulin receptor (IR) …

• Fórmula: C₂₆H₂₃N₅O
• Cor e Forma: Neat
• Peso molecular: 421.49